X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

India Active Pharmaceutical Ingredients (API) Company List

Mordor Intelligence expert advisors identify the Top 5 India Active Pharmaceutical Ingredients (API) companies and the other top companies based on 2024 market position. Get access to the business profiles of top 11 India Active Pharmaceutical Ingredients (API) companies, providing in-depth details on their company overview, key products and services, financials, recent developments and strategic moves.

India Active Pharmaceutical Ingredients (API) Top Companies

trophy

India Active Pharmaceutical Ingredients (API) Market

Top 5 India Active Pharmaceutical Ingredients (API) Companies

  • arrow

    Aurobindo Pharma

  • arrow

    Lupin Ltd

  • arrow

    Viatris Inc.

  • arrow

    Sun Pharmaceutical Industries Ltd

  • arrow

    Teva Pharmaceutical Industries Ltd

 India Active Pharmaceutical Ingredients (API) Market Major Players

Source: Mordor Intelligence

*Top companies in "India Active Pharmaceutical Ingredients (API) Market" based on their market share in 2024, sorted in no particular order

Get market shares and tailor-made intelligence on top players.
Get Free Proposal

Top 5 India Active Pharmaceutical Ingredients (API) Companies

Global Overview Operations in this Market Strengths Strategies & Outlook
Aurobindo Pharma
A leading Indian pharmaceutical company with a strong global presence in over 150 countries. Specializes in producing a wide range of APIs for generic and branded pharmaceuticals. Extensive manufacturing facilities, diverse API portfolio, and strong export capabilities. Focuses on cost efficiency, expanding manufacturing capacity, and developing new APIs for niche markets.
Lupin Ltd
A multinational pharmaceutical company based in India, known for its generic and specialty drugs. Engaged in the production of APIs across various therapeutic areas, including cardiovascular and oncology. Strong R&D capabilities, diversified product offerings, and a robust global supply chain. Investing in innovation, enhancing production technology, and entering strategic partnerships for growth.
Viatris Inc.
A global pharmaceutical company formed from the merger of Mylan and Upjohn, a Pfizer division. Offers a comprehensive range of APIs for both generic and branded pharmaceuticals. Broad API portfolio, strong global distribution network, and a focus on regulatory compliance. Emphasizes global expansion, enhancing R&D capabilities, and focusing on regulatory adherence.
Sun Pharmaceutical Industries Ltd
One of the largest pharmaceutical companies in India with a significant international footprint. Produces APIs for a wide range of therapeutic categories, including chronic and acute conditions. Strong market position in both generic and specialty APIs, with a focus on quality and innovation. Aims to strengthen global presence, innovate product lines, and enhance manufacturing efficiency.
Teva Pharmaceutical Industries Ltd
A leading global pharmaceutical company headquartered in Israel, known for its generics. Engaged in manufacturing APIs for generic medicines, serving markets worldwide. Extensive experience in API production, large-scale manufacturing, and a strong generics market. Focusing on cost leadership, expanding into new markets, and developing specialized APIs to cater to demand.
Uncover market estimates, industry Trends and competitive landscape in a single report
Download PDF

Other Top India Active Pharmaceutical Ingredients (API) Companies

Global Overview Operations in this Market Strengths Strategies & Outlook
Pfizer Inc.
A major global pharmaceutical company with a diverse product portfolio, including innovative medicines. Involved in the production of APIs for its proprietary drugs and biologics. Strong research and development, advanced manufacturing capabilities, and robust market presence. Focusing on innovation, expanding biologics production, and enhancing global supply chain efficiency.
Novartis AG
A Swiss multinational pharmaceutical company specializing in innovative medicines and biosimilars. Engages in the production of APIs for its diverse range of therapeutic products. Extensive R&D investments, advanced technological capabilities, and a broad product portfolio. Investing in cutting-edge technology, expanding biosimilar capabilities, and focusing on sustainability.
BASF SE
A German multinational chemical company, a significant player in the chemicals and materials sector. Produces APIs and intermediates primarily for the pharmaceutical industry, focusing on quality and innovation. Strong expertise in chemical manufacturing, global reach, and innovation in green chemistry. Emphasizes sustainable practices, innovation in API production, and expanding partnerships with pharma companies.
Boehringer Ingelheim GmbH
A global research-driven pharmaceutical company focused on human pharmaceuticals and animal health. Produces APIs for a variety of therapeutic areas, including respiratory and cardiovascular diseases. Strong innovation in research, diverse therapeutic offerings, and commitment to quality. Aiming to expand API production capabilities, invest in R&D, and focus on complex generics and biosimilars.
Sanofi Inc.
A global biopharmaceutical company focused on human health with a wide range of products. Engaged in the production of APIs for its diverse pharmaceutical products, including vaccines. Extensive portfolio of innovative and generic medicines, strong global presence. Investing in advanced manufacturing, enhancing API development, and focusing on regulatory compliance.
GlaxoSmithKline PLC
A global healthcare company focused on pharmaceuticals, vaccines, and consumer healthcare. Involved in producing APIs for its pharmaceuticals and biologics divisions. Strong global presence, extensive R&D capabilities, and diverse product offerings. Emphasizes innovation, expands biologics manufacturing, and maintains a strong focus on quality and compliance.
Dr. Reddy's Laboratories Ltd
An Indian multinational pharmaceutical company specializing in generic medicines and APIs. Produces APIs for both its generic medicines and external pharmaceutical companies. Strong manufacturing capabilities, focus on cost-efficiency, and robust export network. Focuses on expanding global reach, enhancing production efficiency, and developing complex APIs.

Get hard to find intelligence on your customers, suppliers, partners and competitors-backed with on-the-gorund-data.

  • In-depth company profiles
  • Segment level market shares
  • Strategy assessment and SWOT analysis
  • Product portfolio and pricing details
  • Identification and shortlisting of potential partners
  • Need analysis and unmet needs
  • Purchase and usage behavior
  • Partner/customer feedback and satisfaction

Competitive Analysis of Best Companies in India Active Pharmaceutical Ingredients (API) Market

  • Moderately Consolidated Active Pharmaceutical Ingredients Market: Competitive Landscape
    Market Characteristics: The active pharmaceutical ingredients (API) market is characterized by the presence of both global and regional players, with a blend of conglomerates and specialized companies dominating the landscape. The market is moderately consolidated, meaning a few large players hold significant market share, but there is still room for mid-sized and smaller companies. Companies in this market focus on producing APIs for various therapeutic areas, catering to both branded and generic pharmaceuticals. The competition is driven by factors such as quality, cost-efficiency, regulatory compliance, and innovation in production processes.
  • Major Players: The API market is led by companies like Aurobindo Pharma, Lupin Ltd, Viatris Inc., Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. These major players have established themselves through extensive manufacturing capabilities, a wide range of API offerings, and strong distribution networks. Their strengths lie in their ability to meet diverse pharmaceutical needs globally and maintain a high level of compliance with regulatory standards. They also invest heavily in research and development to stay ahead in the competitive market and expand their product portfolios to include complex and niche APIs.
  • Market Trends and Success Strategies: Key trends in the API market include the increasing demand for generic APIs, the focus on sustainable and green chemistry practices, and the growing importance of high-potency APIs (HPAPIs). To achieve success, companies must focus on enhancing their production capabilities, ensuring stringent quality control, and adopting innovative technologies such as continuous manufacturing. Building strategic partnerships and expanding into emerging markets will also be crucial strategies for growth. Additionally, companies need to stay updated with global regulatory changes and invest in developing biosimilar and complex APIs to cater to the evolving pharmaceutical landscape.
Explore More

In-depth Insights on the Top 10 India Active Pharmaceutical Ingredients (API) Companies and more...

India Active Pharmaceutical Ingredients (API) Companies

  • Aurobindo Pharma
  • Pfizer Inc.
  • Novartis AG
  • BASF SE
  • Boehringer Ingelheim GmbH
  • Viatris Inc.
  • Sanofi Inc.
  • GlaxoSmithKline PLC
  • Dr. Reddy's Laboratories Ltd
  • Lupin Ltd
  • Sun Pharmaceutical Industries Ltd

Insights Cover

  • Global Level Overview
  • Market Level Overview
  • Core Business Segmengts
  • Financials
  • Employee Headcount
  • Market Rank and Market Share
  • Products and Services
  • Recent Developments
  • Key Strategic Moves
  • List Of Companies

API Market in India Size - Industry Report on Share, Growth Trends & Forecasts Analysis (2024 - 2029)